menu
    • menu

    Company profile for Vertex Pharmaceuticals

    NEW Drugs in Dev: 49
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Vertex, we have some of the industry's best and brightest people helping us achieve our mission of discovering transformative medicines to help people with serious diseases like cystic fibrosis. Whether they are in the lab, part of our business development team or on the phones with patients, we depend on a talented global workforce to lead the charge as we work toward developing tomorrow's breakthrough medicines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vertex PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 Northern Avenue Boston, MA 02210
    Telephone
    Telephone
    +1(617)-341-6100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vrtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vertex-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vertex To Report Q1 2026 Financial Results On May 4
    Vertex To Report Q1 2026 Financial Results On May 4

    06 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-06/vertex-to-announce-first-quarter-2026-financial-results-on-may-4th

    PHARMIWEB
    06 Apr 2026
    Share Share
    Vertex Gets FDA Label Expansion For Alyftrek And Trikafta
    Vertex Gets FDA Label Expansion For Alyftrek And Trikafta

    01 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-01/vertex-announces-us-fda-approval-for-label-extensions-of-alyftrek-and-trikafta-expanding-availabi

    PHARMIWEB
    01 Apr 2026
    Share Share
    Vertex Rushes FDA Filing on Strong Phase 3 Kidney Data
    Vertex Rushes FDA Filing on Strong Phase 3 Kidney Data

    10 Mar 2026

    // PRESS RELEASE

    https://news.vrtx.com/news-releases/news-release-details/vertex-announces-positive-week-36-interim-analysis-results

    PRESS RELEASE
    10 Mar 2026
    Share Share
    Vertex Terminates 20 in Reorganization Push
    Vertex Terminates 20 in Reorganization Push

    09 Mar 2026

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    09 Mar 2026
    Share Share
    Vertex Announces Positive Week 36 Interim Analysis Results
    Vertex Announces Positive Week 36 Interim Analysis Results

    09 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260309179428/en/Vertex-Announces-Positive-Week-36-Interim-Analysis-Results-for-Primary-and-All-Secondary-Endpoints-in-the-RAINIER-Phase-3-Trial-of-Povetacicept-in-Adults-With-IgA-Nephropathy

    BUSSINESSWIRE
    09 Mar 2026
    Share Share
    Vertex Presents JOURNAVX Data on Effective Pain Management
    Vertex Presents JOURNAVX Data on Effective Pain Management

    05 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-05/vertex-to-present-new-data-on-journavx-that-demonstrates-effective-pain-management-following-aesthe

    PHARMIWEB
    05 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search